Literature DB >> 19029450

The dilemma of anticancer therapy: tumor-specific versus immune effects.

Laurence Zitvogel1, Guido Kroemer.   

Abstract

Entities:  

Year:  2008        PMID： 19029450     DOI： 10.1182/blood-2008-09-176693

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.

Authors:  Douglas W McMillin; Jake Delmore; Joseph M Negri; Matthew Vanneman; Shohei Koyama; Robert L Schlossman; Nikhil C Munshi; Jacob Laubach; Paul G Richardson; Glenn Dranoff; Kenneth C Anderson; Constantine S Mitsiades
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

2.  PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.

Authors:  Bola S Hanna; Philipp M Roessner; Annika Scheffold; Billy M C Jebaraj; Yasmin Demerdash; Selcen Öztürk; Peter Lichter; Stephan Stilgenbauer; Martina Seiffert
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

3.  Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells.

Authors:  Timothy J Haggerty; Ian S Dunn; Lenora B Rose; Estelle E Newton; Sunil Martin; James L Riley; James T Kurnick
Journal:  Cancer Immunol Immunother       Date:  2010-10-30       Impact factor: 6.968

4.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

Authors:  David G DeNardo; Donal J Brennan; Elton Rexhepaj; Brian Ruffell; Stephen L Shiao; Stephen F Madden; William M Gallagher; Nikhil Wadhwani; Scott D Keil; Sharfaa A Junaid; Hope S Rugo; E Shelley Hwang; Karin Jirström; Brian L West; Lisa M Coussens
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

5.  High-throughput approaches to discover novel immunomodulatory agents for cancer.

Authors:  Douglas W McMillin; Constantine S Mitsiades
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

6.  Targeting PI3Kδ: One man's meat is another man's poison.

Authors:  Michaela Prchal-Murphy; Eva Maria Putz; Michael Freissmuth; Veronika Sexl; Eva Zebedin-Brandl
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.